Robert Merrill Hunter's Net Worth

$11.4 Million

Estimate Recalculated Sep 8, 2024 07:22PM EST

Who is Robert Merrill Hunter?

Robert Merrill Hunter has an estimated net worth of $11.4 Million. This is based on reported shares across multiple companies, which include Synergy Pharmaceuticals, Inc., TrovaGene Inc., and CALLISTO PHARMACEUTICALS INC.

SEC CIK

Robert Merrill Hunter's CIK is 0001507797

Past Insider Trading and Trends

2012 was Robert Merrill Hunter's most active year for acquiring shares with 2 total transactions. Robert Merrill Hunter's most active month to acquire stocks was the month of March. 2012 was Robert Merrill Hunter's most active year for disposing of shares, totalling 1 transactions. Robert Merrill Hunter's most active month to dispose stocks was the month of December. 2012 saw Robert Merrill Hunter paying a total of $200,000.00 for 800,000 shares, this is the most they've acquired in one year. In 2013 Robert Merrill Hunter cashed out on 21,891,922 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Synergy Pharmaceuticals, Inc. No price found

Investor

Robert Merrill Hunter owns 7,243,557 units of Common Stock. In the year 2013 Robert Merrill Hunter filed a total of 1 filing.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+119.16%
3.94M
—
—
7.24M
Jan 17
No matching records found

TrovaGene Inc. (CRDF) Snapshot price: $2.3

Investor

Robert Merrill Hunter owns 5,065,004 units of Common Stock which is worth $11,649,509.20. In the year 2012 Robert Merrill Hunter filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.57%
400K
$0.50
$200,000.00
5.07M
Apr 13
Form 3
—
0
—
—
0
No matching records found

CALLISTO PHARMACEUTICALS INC No price found

Investor

Robert Merrill Hunter used to own units in Common Stock but no longer holds any shares there. From 2010 to 2013 Robert Merrill Hunter disposed a total of 33,891,922 shares of CALLISTO PHARMACEUTICALS INC.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-21.89M
—
—
0
Jan 17
Form 4
-32.11%
-12.00M
—
—
25.38M
Mar 26
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found